Ambu
133.55
DKK
-0.15 %
AMBU B
NASDAQ Copenhagen
Medical Equipment & Services
Health Care
Less than 1K followers
-0.15%
+27.01%
+28.41%
+2.97%
-0.04%
+24.58%
-3.85%
+9.92%
+13,775.32%
Ambu is active in medical technology. The company develops and markets diagnostic equipment for actors in healthcare. The largest activity is found in the development of solutions for endoscopy, gastroscopy and patient monitoring. Operations are held on a global level with the largest presence in Europe and North America. Ambu was founded in 1937 and is headquartered in Ballerup, Denmark.
Read moreMarket cap
35.96B DKK
Turnover
44.04M DKK
Revenue
5.39B
EBIT %
5.77 %
P/E
151.76
Dividend yield-%
0.28 %
Financial calendar
7.5
2025
Interim report Q2'25
22.8
2025
Interim report Q3'25
5.11
2025
Annual report '25
ShowingAll content types
INTERIM REPORT FOR Q1 2024/25
AMBU RAISES FINANCIAL OUTLOOK FOR 2024/25
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Aktier i Vælten - Et tilbageblik på bevægelserne i OMXC25 i 2024, og nogle forudsigelser for 2025
DECISIONS OF THE ANNUAL GENERAL MEETING OF AMBU A/S
Reporting of transactions made by persons discharging managerial responsibilities
Reporting of transactions made by persons discharging managerial responsibilities
Reporting of transactions made by persons dischargingmanagerial responsibilities
NOTICE OF THE ANNUAL GENERAL MEETING 2024 OF AMBU A/S
Reporting of transactions made by persons discharging managerial responsibilities
ANNUAL REPORT 2023/24
INTERIM REPORT FOR Q4 AND THE FULL-YEAR 2023/24 RESULTS (UNAUDITED)
AMBU ANNOUNCES FINANCIAL OUTLOOK FOR THE 2024/25 FINANCIAL YEAR
AMBU FINANCIAL CALENDAR FOR 2024/25
Major shareholder announcements
INTERIM REPORT FOR Q3 2023/24
AMBU INCREASES FINANCIAL OUTLOOK FOR THE 2023/24 FINANCIAL YEAR
INTERIM REPORT FOR Q2 2023/24 AND THE HALF-YEAR